AI assistant
ABBOTT LABORATORIES — Director's Dealing 2005
Feb 23, 2005
29777_dirs_2005-02-23_b6d2be9c-ccc5-4f1e-a702-45bbf40d3c7b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2005-02-18
Reporting Person: LEIDEN JEFFREY M (Director, President and COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-02-18 | Common shares without par value | A | 46400 | $46.34 | Acquired | 323292 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2005-02-18 | Option (right to buy) | $46.34 | A | 313200 | Acquired | 2015-02-17 | common shares (313200) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 619 | Indirect |
Footnotes
F1: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes.
F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 17, 2005.
F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 104,400 on 2/18/06, 104,400 on 2/18/07 and 104,400 on 2/18/08.